Patents by Inventor Natalie ANOSOVA

Natalie ANOSOVA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VACCINES AGAINST SARS-COV-2 INFECTIONS
    Publication number: 20240016918
    Abstract: Provided are novel vaccines for prophylactic treatment of SARS-CoV-2 infections and COVID-19 and methods of making the vaccines.
    Type: Application
    Filed: August 23, 2021
    Publication date: January 18, 2024
    Applicant: SANOFI PASTEUR INC.
    Inventors: Natalie ANOSOVA, Salvador Fernando AUSAR, Catherine BERRY, Florence BOUDET, Danilo CASIMIRO, Roman M. CHICZ, Gustavo DAYAN, Guy DE BRUYN, Carlos DIAZGRANADOS, Tong-Ming FU, Marie GARINOT, Lorry GRADY, Sanjay GURUNATHAN, Kirill KALNIN, Nikolai KHRAMTSOV, Valérie LECOUTURIER, Nausheen RAHMAN, Sophie RUIZ, Stephen SAVARINO, Saranya SRIDHAR, Indresh K. SRIVASTAVA, James TARTAGLIA, Timothy TIBBITTS
  • HUMAN METAPNEUMOVIRUS VACCINES
    Publication number: 20230310571
    Abstract: The present disclosure provides antigenic prefusion hMPV F polypeptides, nucleic acid sequences (e.g., RNA sequences, e.g., mRNA sequences) encoding prefusion hMPV F polypeptides, compositions comprising antigenic prefusion hMPV F polypeptides, compositions comprising nucleic acid sequences encoding prefusion hMPV F polypeptides, and hMPV vaccines.
    Type: Application
    Filed: November 29, 2022
    Publication date: October 5, 2023
    Inventors: Yvonne Chan, Sukanya Sasmal, Antonia Stuebler, Michael Kishko, Sophia Mundle, Linong Zhang, Josh DiNapoli, Judith Alamares-Sapuay, Natalie Anosova, Sudha Chivukula, Hillary Danz, Tod Strugnell, Rachel Groppo
  • ANTIBODIES AGAINST CLOSTRIDIUM DIFFICILE TOXINS AND METHODS OF USING THE SAME
    Publication number: 20220089700
    Abstract: Monoclonal antibodies, or antigen-binding fragments thereof, that bind to Clostridium difficile (C. difficile) toxin A or toxin B and methods of using the same to detect or treat C. difficile infections and/or C. difficile-associated disease.
    Type: Application
    Filed: November 30, 2021
    Publication date: March 24, 2022
    Inventors: Stephen F. Anderson, Natalie Anosova, Nicola Beltraminelli, Pierre Garrone, Harold Kleanthous, Majid Mehtali, Jianxin Zhang
  • Antibodies against toxins and methods of using the same
    Patent number: 11220537
    Abstract: Monoclonal antibodies, or antigen-binding fragments thereof, that bind to Clostridium difficile (C. difficile) toxin A or toxin B and methods of using the same to detect or treat C. difficile infections and/or C. difficile-associated disease.
    Type: Grant
    Filed: November 29, 2018
    Date of Patent: January 11, 2022
    Assignee: SANOFI PASTEUR BIOLOGICS, LLC
    Inventors: Stephen F. Anderson, Natalie Anosova, Nicola Beltraminelli, Pierre Garrone, Harold Kleanthous, Jianxin Zhang, Majid Mehtali
  • ANTIBODIES AGAINST CLOSTRIDIUM DIFFICILE TOXINS AND METHODS OF USING THE SAME
    Publication number: 20190153078
    Abstract: Monoclonal antibodies, or antigen-binding fragments thereof, that bind to Clostridium difficile (C. difficile) toxin A or toxin B and methods of using the same to detect or treat C. difficile infections and/or C. difficile-associated disease.
    Type: Application
    Filed: November 29, 2018
    Publication date: May 23, 2019
    Inventors: Stephen F. Anderson, Natalie Anosova, Nicola Beltraminelli, Pierre Garrone, Harold Kleanthous, Jianxin Zhang, Majid Mehtali
  • Antibodies against toxins and methods of using the same
    Patent number: 10160797
    Abstract: Monoclonal antibodies or antigen-binding fragments thereof, that bind to Clostridium difficile (C. difficile ) toxin A or toxin B and methods of using the same to detect or treat C. difficile infections and/or C. difficile -associated disease. C. difficile is a gram positive, anaerobic bacterium that causes gastrointestinal disease in humans. The bacteria are transmitted through feces and spread to food and other surfaces when people who are infected do not thoroughly wash their hands.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: December 25, 2018
    Assignee: SANOFI PASTEUR BIOLOGICS, LLC
    Inventors: Stephen F. Anderson, Natalie Anosova, Nicola Beltraminelli, Pierre Garrone, Harold Kleanthous, Jianxin Zhang, Majid Mehtali
  • ANTIBODIES AGAINST CLOSTRIDIUM DIFFICILE TOXINS AND METHODS OF USING THE SAME
    Publication number: 20160068591
    Abstract: Monoclonal antibodies or antigen-binding fragments thereof that bind to Clostridium difficile (C. difficile) toxin A or toxin B and methods of using the same to detect or treat C. difficile infections and/or C. difficile-associated disease. C. difficile is a gram positive, anaerobic bacterium that causes gastrointestinal disease in humans. The bacteria are transmitted through feces and spread to food and other surfaces when people who are infected do not thoroughly wash their hands.
    Type: Application
    Filed: March 14, 2014
    Publication date: March 10, 2016
    Applicant: Sanofi Pasteur Biologics, LLC
    Inventors: Stephen F. ANDERSON, Natalie ANOSOVA, Nicola BELTRAMINELLI, Pierre GARRONE, Harold KLEANTHOUS, Jianxin ZHANG, Majid MEHTALI